Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-11-13 4:30 pm Purchase | 2024-09-30 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | Rubric Capital Management LP | 2,419,103 5.960% | 2,419,103![]() (New Position) | Filing History |
2024-11-13 4:30 pm Purchase | 2024-09-30 | 13G | Schrödinger, Inc. SDGR | Rubric Capital Management LP | 3,685,503 5.790% | 3,685,503![]() (New Position) | Filing History |
2024-11-13 4:30 pm Purchase | 2024-09-30 | 13G | Seaport Entertainment Group Inc. SEG | Rubric Capital Management LP | 276,942 5.020% | 276,942![]() (New Position) | Filing History |
2024-11-13 4:30 pm Sale | 2024-09-30 | 13G | Sutro Biopharma, Inc. STRO | Rubric Capital Management LP | 0 0.000% | -3,344,810![]() (Position Closed) | Filing History |
2024-11-13 4:30 pm Purchase | 2024-09-30 | 13G | Talen Energy Corporation TLN | Rubric Capital Management LP | 11,368,614 22.290% | 11,368,614![]() (New Position) | Filing History |
2024-11-13 4:30 pm Purchase | 2024-09-30 | 13G | Adaptive Biotechnologies Corporation ADPT | Rubric Capital Management LP | 14,400,000 9.760% | 14,400,000![]() (New Position) | Filing History |
2024-11-13 4:30 pm Sale | 2024-09-30 | 13G | ANI Pharmaceuticals, Inc. ANIP | Rubric Capital Management LP | 56,671 0.270% | -1,068,329![]() (-94.96%) | Filing History |
2024-11-13 4:30 pm Sale | 2024-09-30 | 13G | BGC Group, Inc BGC | Rubric Capital Management LP | 16,972,580 4.500% | -3,027,420![]() (-15.14%) | Filing History |
2024-11-13 4:30 pm Purchase | 2024-09-30 | 13G | Dole plc DOLE | Rubric Capital Management LP | 5,141,388 5.410% | 5,141,388![]() (New Position) | Filing History |
2024-11-13 4:30 pm Sale | 2024-09-30 | 13G | Collegium Pharmaceutical, Inc. COLL | Rubric Capital Management LP | 1,250,000 3.880% | -1,508,253![]() (-54.68%) | Filing History |
2024-11-13 4:30 pm Sale | 2024-09-30 | 13G | GoodRx Holdings, Inc. GDRX | Rubric Capital Management LP | 4,680,028 4.750% | -1,192,778![]() (-20.31%) | Filing History |
2024-11-13 4:30 pm Sale | 2024-09-30 | 13G | Werewolf Therapeutics, Inc. HOWL | Rubric Capital Management LP | 1,333,893 3.050% | -601,464![]() (-31.08%) | Filing History |
2024-11-13 4:30 pm Purchase | 2024-09-30 | 13G | Stratasys Ltd. SSYS | Rubric Capital Management LP | 6,191,000 8.670% | 1,941,000![]() (+45.67%) | Filing History |
2024-11-13 4:30 pm Purchase | 2024-09-30 | 13G | Pediatrix Medical Group, Inc. MD | Rubric Capital Management LP | 8,275,000 9.640% | 8,275,000![]() (New Position) | Filing History |
2024-11-13 4:30 pm Purchase | 2024-09-30 | 13G | Arcutis Biotherapeutics, Inc. ARQT | Rubric Capital Management LP | 48,706,640 6.980% | 48,706,640![]() (New Position) | Filing History |
2024-11-13 4:30 pm Purchase | 2024-09-30 | 13G | QuidelOrtho Corporation QDEL | Rubric Capital Management LP | 4,200,000 6.250% | 4,200,000![]() (New Position) | Filing History |
2024-11-13 4:30 pm Purchase | 2024-09-30 | 13G | ReNew Energy Global Plc RNW | Rubric Capital Management LP | 13,706,102 5.610% | 13,706,102![]() (New Position) | Filing History |
2024-11-13 4:30 pm Sale | 2024-09-30 | 13G | Trevi Therapeutics, Inc. TRVI | Rubric Capital Management LP | 5,026,931 6.920% | -657,489![]() (-11.57%) | Filing History |
2024-11-13 4:30 pm Purchase | 2024-09-30 | 13G | Zymeworks Inc. ZYME | Rubric Capital Management LP | 3,917,331 5.510% | 3,917,331![]() (New Position) | Filing History |
2024-06-17 4:32 pm Purchase | 2024-06-17 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 108,486,735 14.200% | 8,771,750![]() (+8.80%) | Filing History |